8-[4-(1-氨基环丁基)苯基]-9-苯基-1,2,4-噻唑并[3,4-f][1,6]萘啶-3(2H)-酮

• 常用名: 8-[4-(1-氨基环丁基)苯基]-9-苯基-1,2,4-噻唑并[3,4-f][1,6]萘啶-3(2H)-酮
• 英文名: MK-2206 free base
• CAS号: 1032349-93-1
• 分子量: 407.46700
• 密度: N/A
• 沸点: N/A
• 分子式: C₂₅H₂₁N₅O
• 熔点: N/A
• 闪点: N/A

用途

MK-2206 free base 是一种具有口服活性的,高效选择性的,变构 Akt 抑制剂,对 Akt1、Akt2 和 Akt3 中的 IC50 分别为 8、12 和 65 nM。许多乳腺癌细胞系、PIK3CA 突变体和 PTEN 丢失细胞系对 MK-2206 free base 敏感。MK-2206 free base 具有抗癌活性。

名称

• 中文名: 8-[4-(1-氨基环丁基)苯基]-9-苯基-1,2,4-噻唑并[3,4-f][1,6]萘啶-3(2H)-酮
• 英文名: 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-2H-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-one

生物活性

• 描述: MK-2206 free base 是一种具有口服活性的,高效选择性的,变构 Akt 抑制剂,对 Akt1、Akt2 和 Akt3 中的 IC50 分别为 8、12 和 65 nM。许多乳腺癌细胞系、PIK3CA 突变体和 PTEN 丢失细胞系对 MK-2206 free base 敏感。MK-2206 free base 具有抗癌活性。
• 相关类别:
  信号通路 >> 细胞凋亡 >> 细胞凋亡
  研究领域 >> 癌症
  信号通路 >> 自噬 >> 自噬
  信号通路 >> PI3K/Akt/mTOR 信号通路 >> AKT
• 靶点实验:

  Akt1:8 nM (IC50)

  Akt2:12 nM (IC50)

  Akt3:65 nM (IC50)

• 参考文献:

  [1]. Li Yan, et al. Abstract #DDT01-1: MK-2206: A potent oral allosteric AKT inhibitor. 2009.

  [2]. Zhao YY, et al. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo. Drug Des Devel Ther. 2014 Oct 10;8:1827-37.

  [3]. Xing Y, et al. Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation. Breast Cancer Res. 2019 Jul 5;21(1):78.

  [4]. Agarwal E, et al. Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer. BMC Cancer. 2014 Mar 1;14:145.

  [5]. Zhao YY, et al. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo. Drug Des Devel Ther. 2014 Oct 10;8:1827-37.

物理化学性质

• 分子式: C₂₅H₂₁N₅O
• 分子量: 407.46700
• 精确质量: 407.17500
• PSA: 89.33000
• LogP: 5.35530
• InChIKey: ULDXWLCXEDXJGE-UHFFFAOYSA-N
• SMILES: NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1

靶点实验

查看更多实验

实验名称：Ratio of IC50 for inhibition of AKT3 in human ANBL6 cells assessed as reduction of ce... 来源：ChEMBL 靶标：RAC-gamma serine/threonine-protein kinase External Id：CHEMBL5720021

实验名称：Ratio of IC50 for inhibition of AKT2 in human ANBL6 cells assessed as reduction of ce... 来源：ChEMBL 靶标：RAC-beta serine/threonine-protein kinase External Id：CHEMBL5720020

实验名称：Primary qHTS assay for inhibitors of alpha-synuclein gene (SNCA) expression 来源：NCGC External Id：SNCA-p-activity-luciferase

实验名称：Cytochrome P450 Family 1 Subfamily A Member 2 (CYP1A2) small molecule antagonists: lu... 来源：824 External Id：CYP273

实验名称：Quantitative High-Throughput drug screen in 47 multiple myeloma cell lines against th... 来源：NCGC 靶标：N/A External Id：s-my-keats_OPM1-m4-1

实验名称：Quantitative High-Throughput drug screen in 47 multiple myeloma cell lines against th... 来源：NCGC 靶标：N/A External Id：s-my-OC1MY5-m4-1

实验名称：Quantitative High-Throughput drug screen in 47 multiple myeloma cell lines against th... 来源：NCGC 靶标：N/A External Id：s-my-KMS_34-m4-1

实验名称：Quantitative High-Throughput drug screen in 47 multiple myeloma cell lines against th... 来源：NCGC 靶标：N/A External Id：s-my-keats_L363-m4-1

实验名称：Quantitative High-Throughput drug screen in 47 multiple myeloma cell lines against th... 来源：NCGC 靶标：N/A External Id：s-my-keats_OCIMY7-m4-1

实验名称：Quantitative High-Throughput drug screen in 47 multiple myeloma cell lines against th... 来源：NCGC 靶标：N/A External Id：s-my-MM1R-m4-1

共1234条，当前第1页，共124页

1

2

3

4

5

英文别名

• UNII-51HZG6MP1K
• MK-2206 dihydrochloride